Zydus Group

GPTKB entity

Statements (58)
Predicate Object
gptkbp:instance_of gptkb:Company
gptkbp:bfsLayer 4
gptkbp:bfsParent gptkb:Zydus_Cadila
gptkbp:acquisition Liva Healthcare
Mylan's non-US generics business
gptkbp:category gptkb:skincare_product
animal health products
prescription medications
nutraceuticals
OTC products
gptkbp:clinical_trial conducts clinical trials globally
gptkbp:collaborations academic institutions
research organizations
gptkbp:community_engagement supports local communities
promotes health awareness
provides healthcare access
gptkbp:employees over 25,000
gptkbp:founded gptkb:1995
gptkbp:founder gptkb:Pankaj_R._Patel
gptkbp:headquarters gptkb:Ahmedabad,_India
https://www.w3.org/2000/01/rdf-schema#label Zydus Group
gptkbp:industry Pharmaceuticals
gptkbp:invention holds numerous patents
gptkbp:investment in biotechnology
in biosimilars
in digital health
in vaccine development
gptkbp:leadership Dr. R. S. Sharma is the Chief Scientific Officer
Pankaj R. Patel is the Chairman
Sharvil Patel is the Managing Director
gptkbp:market global
over 100 countries
gptkbp:partnership gptkb:Bristol-Myers_Squibb
gptkb:Gilead_Sciences
with government for health programs
gptkbp:products generic drugs
vaccines
biologics
gptkbp:rank among top 50 pharmaceutical companies
gptkbp:regulatory_compliance gptkb:FDA
gptkb:WHO
gptkb:EMA
gptkbp:research Dr. Sharvil Patel
gptkbp:research_and_development focus on oncology
focus on infectious diseases
focus on chronic diseases
focus on cardiovascular diseases
focus on diabetes
gptkbp:revenue over $2 billion
gptkbp:social_responsibility environmental initiatives
education initiatives
healthcare initiatives
gptkbp:subsidiary gptkb:Zydus_Cadila
gptkbp:sustainability_initiatives water conservation programs
renewable energy usage
reducing carbon footprint
waste management initiatives
gptkbp:website www.zyduscadila.com